Year 2017 / Volume 109 / Number 8
Original
Epidemiology of inflammatory bowel disease in Málaga: incidence rate and follow-up of a cohort diagnosed between 2007-2008

572-577

DOI: 10.17235/reed.2017.4708/2016

Ignacio Cueto Torreblanca, Raquel Camargo Camero, Raúl Andrade Bellido, Eduardo Romero Pérez, Guillermo Alcaín Martínez,

Abstract
Background and objectives: The incidence of inflammatory bowel disease (IBD) in Spain has been traditionally lower than in Northern European countries. Recent epidemiological studies have found that these differences are diminishing. This study estimates the incidence of IBD in Málaga (Spain), a city in Southern Spain and relates its results to those found in our neighboring countries. Material and methods: This was a prospective study designed to collect new cases diagnosed during the period from 2007-2008 and follow up these patients. Incidence is expressed as number of patients per 100,000 population per year. The population distribution found in the European Collaborative Study was used to standardize incidence rates. Results: The gross incidence rate of IBD in Málaga is 9/105, the standardized incidence rate is 12.3/105 (9.7-15.6). Conclusions: These data are similar to those found in our surroundings, although a higher incidence rate for Crohn's disease (CD) as compared to ulcerative colitis (UC) was found. The clinical characteristics and outcomes of our patients do not differ significantly from those described for other populations.
Share Button
New comment
Comments
No comments for this article
References
1 - Pajares JM, Gisbert JP. Epidemiología de la enfermedad inflamatoria intestinal en
España. Una revisión sistemática. Rev Esp Enferm Dig 2001; 93: 9-14.
2 - Shivananda S, Lennard-Jones J, Logan R, et al. Incidence of inflammatory bowel
disease across Europe: is there a difference between north and south? Results of the
European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 1996;
39: 690–7.
3 - Burisch J, Pedersen N, Čuković-Čavka S, et al; EpiCom-group. East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort. Gut. 2014; 63:588-97.
4 - Martinez G, Fernandez Y, Rodrigo Saez L, et al. Estudio epidemiológico de la Enfermedad de Crohn en la región de Asturias. Rev Esp Enferm Apar Dig 1983; 63: 534–41.
5 - Ruiz Ochoa V. Estudio epidemiológico de la enfermedad de Crohn en Galicia en el período de 1976 a 1983. Rev Esp Enferm Apar Dig 1984; 66: 273–9.
6 - Sebastian Domingo JJ, Banares Canizares R, Velo Bellver JL, et al. Los aspectos epidemiológicos de la Enfermedad inflamatoria intestinal crónica en un área de la Comunidad Autónoma de Madrid. An Med Interna 1989; 6: 519–22.
7 - Hinojosa J, Primo J, Lledo S, et al. Incidencia de Enfermedad inflamatoria intestinal en Sagunto. Rev Esp Enferm Dig 1990; 78: 283–7.
8 - Brullet E, Rue M, Montserrat A, et al. Un estudio epidemiológico descriptivo de Colitis ulcerosa en una población hospitalaria (1985–1989). Med Clin 1991; 97: 45–9.
9 - Sola Lamoglia R, Garcia-Puges AM, Mones Xiol J, et al. Enfermedad inflamatoria intestinal en Cataluña (Barcelona y Gerona). Rev Esp Enferm Dig 1992; 81: 7–14.
10 - Martinez-Salmeron JF, Rodrigo M, de Teresa J, et al. Epidemiología de Enfermedad inflamatoria intestinal en la provincial de Granada, España: un studio prospectivo de 1979 a 1988. Gut 1993; 34: 1207–9.
11 - Mate-Jimenez J, Munoz S, Vicent D, et al. Incidence and prevalence of ulcerative colitis and Crohn’s disease in urban and rural areas of Spain from 1981 to 1988. J Clin Gastroenterol 1994; 18: 27–31.
12 - Arin Letamendia A, Burusco Paternain MJ, Borda Celaya F, et al. Epidemiological aspects of inflammatory bowel disease in the Pamplona area. Rev Esp Enferm Dig 1999; 91: 769–76.
13 - Brullet E, Bonfill X, Urrútia G, et al. Estudio epidemiológico sobre la incidencia de enfermedad inflamatoria intestinal en cuatro áreas españolas. Med Clin 1998; 110: 651-6.
14 - Lopez Miguel C, Sicilia B, Sierra E, et al. Incidence of inflammatory bowel disease in Aragon: outcome of a prospective population-based study. Gastroenterol Hepatol 1999; 22: 323–8.
15 - Garrido A, Martinez MJ, Ortega JA, et al. Epidemiology of chronic inflammatory bowel disease in the Northern area of Huelva. Rev Esp Enferm Dig 2004; 96: 687-94.
16 - Rodrigo L, Riestra S, Nino P, et al. A population-based study on the incidence of inflammatory bowel disease in Oviedo (Northern Spain). Rev Esp Enferm Dig 2004; 96: 296–305.
17 - Lopez-Serrano P, Perez-Calle JL, Carrera-Alonso E, et al. Epidemiologic study on the current incidence of inflammatory bowel disease in Madrid. Rev Esp Enferm Dig 2009; 101: 768–72.
18 - Arin Letamendia A, Borda Celaya F, Burusco Paternain MJ, et al. High incidence rates of inflammatory bowel disease in Navarra (Spain). Results of a prospective, population-based study. Gastroenterol Hepatol 2008; 31: 111–6.
19 -Fernández A, Hernández V, Martínez-Ares D, et al; EpiCom Group. Incidence and phenotype at diagnosis of inflammatory bowel disease. Results in Spain of the EpiCom study. Gastroenterol Hepatol. 2015 Nov; 38(9):534-40.
20 - Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989; 24 (Suppl 170): 2-6.
21 - Ott C, Obermeier F, Thieler S, et al. The incidence of inflammatory bowel disease in a rural region of Southern Germany: a prospective population-based study. 2008 ;20(9): 917-23.
22 - Sincić BM, Vucelić B, Persić M, et al. Incidence of inflammatory bowel disease in Primorsko-goranska County, Croatia, 2000-2004: A prospective population-based study. Scand J Gastroenterol. 2006; 41: 437-44.
23 - Molodecky NA, Soon IS, Rabi DM et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012; 142: 46-54.
24 - Molodecky NA, Soon IS, Rabi DM et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012; 142: 46-54.
25 - Jess T, Riis L, Vind I et al. Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark. Inflamm Bowel Dis 2007; 13: 481-9.
26 - Louis E, Collard A, Oger AF, et al. Behaviour of Crohn’s disease according to the Vienna classification: changing pattern over the course of the disease. Gut 2001; 49: 777–82.
27 - Romberg-Camps MJ, Dagnelie PC, Kester AD et al. Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease. Am J Gastroenterol 2009; 104: 371-83.
28- Burisch J, Pedersen N, Cukovic-Cavka S, et al. Initial disease course and treatment in an inflammatory bowel disease inception cohort in Europe: The ECCO-EpiCom Cohort. Inflamm Bowel Dis 2014; 20: 36-46.
Related articles

Letter

Hepatosplenic T-cell lymphoma and inflammatory bowel disease

DOI: 10.17235/reed.2023.9472/2023

Review

Clinical settings with tofacitinib in ulcerative colitis

DOI: 10.17235/reed.2022.8660/2022

Letter

Anal neoplasia and perianal Crohn’s disease: myth or reality?

DOI: 10.17235/reed.2021.8317/2021

Letter

Apoptotic colopathy as a manifestation of Good’s syndrome

DOI: 10.17235/reed.2021.8297/2021

Original

Radon exposure and inflammatory bowel disease in a radon prone area

DOI: 10.17235/reed.2021.8239/2021

Review

Inflammatory bowel disease and solid organ transplantation

DOI: 10.17235/reed.2020.7361/2020

Editorial

Is celiac disease really associated with inflammatory bowel disease?

DOI: 10.17235/reed.2019.6779/2019

Original

Megacolon in inflammatory bowel disease: response to infliximab

DOI: 10.17235/reed.2020.6394/2019

Editorial

Diet in the etiology of inflammatory bowel disease

DOI: 10.17235/reed.2018.6119/2018

Case Report

Serrated Lesions in patients with Inflammatory Bowel Disease.

DOI: 10.17235/reed.2019.5910/2018

Editorial

Online social networks and inflammatory bowel disease

DOI: 10.17235/reed.2018.5496/2018

Letter to the Editor

Idiopathic portal hypertension with regard to thiopurine treatment

DOI: 10.17235/reed.2018.5256/2017

Editorial

Specialist care in the management of inflammatory bowel disease

DOI: 10.17235/reed.2016.4628/2016

Citation tools
Cueto Torreblanca I, Camargo Camero R, Andrade Bellido R, Romero Pérez E, Alcaín Martínez G. Epidemiology of inflammatory bowel disease in Málaga: incidence rate and follow-up of a cohort diagnosed between 2007-2008. 4708/2016


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 990 visits.
This article has been downloaded 260 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 02/11/2016

Accepted: 21/01/2017

Online First: 10/07/2017

Published: 31/07/2017

Article revision time: 64 days

Article Online First time: 250 days

Article editing time: 271 days


Share
This article has been rated by 2 readers.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2023 y Creative Commons. The Spanish Journal of Gastroenterology